During the past decade, Timber Lane Allergy and Asthma Research LLC conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Timber Lane Allergy and Asthma Research LLC" are "Asthma" (2 trials) and "Urticaria" (2 trials). Many other conditions were trialed in "Timber Lane Allergy and Asthma Research LLC" in a lesser frequency.

Most popular intervention types in "Timber Lane Allergy and Asthma Research LLC" are "Drug" (3 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "GDC-0853" (2 trials), "Placebo" (2 trials), "Budesonide/Formoterol fumarate dihydrate" (1 trials), "IMA-638" (1 trials) and "Symbicort" (1 trials). Other intervention names were less common.

The vast majority of trials in "Timber Lane Allergy and Asthma Research LLC" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Timber Lane Allergy and Asthma Research LLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Timber Lane Allergy and Asthma Research LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Timber Lane Allergy and Asthma Research LLC, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".